Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis-Reference-Cited by-同舟云学术

Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

Published:2013-12-16 Issue:3 Volume:74 Page:538-546
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Kay Jonathan,Fleischmann Roy,Keystone Edward,Hsia Elizabeth C,Hsu Benjamin,Mack Michael,Goldstein Neil,Braun Jürgen,Kavanaugh Arthur

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference48 articles.

1. Abbott Laboratories. Humira (adalimumab) [highlights of prescribing information]. Last revised September 2012. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125057s232lbl.pdf (accessed 17 Apr 2013).

2. UCB Inc. Cimzia (certolizumab) [highlights of prescribing information]. Last revised November 2012. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125160s189lbl.pdf (accessed 17 Apr 2013).

3. Amgen Wyeth, manufactured by Immunex. Enbrel (etanercept) [highlights of prescribing information]. Last revised December 2012. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/103795s5507lbl.pdf (accessed 17 Apr 2013).

4. Janssen Biotech, Inc. Remicade (infliximab) [highlights of prescribing information]. Last revised March 2013. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103772s5345lbl.pdf (accessed 17 Apr 2013).

5. Janssen Biotech, Inc. Simponi (golimumab) [highlights of prescribing information]. Last revised November 2012. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125289s070lbl.pdf (accessed 17 Apr 2013).

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of immune regulation and differentiation dysfunction of mesenchymal stem cells on the disease process in ankylosing spondylitis and prospective analysis of stem cell transplantation therapy;Postgraduate Medical Journal;2023-09-09

2. New Generation Smart Drug Delivery Systems for Rheumatoid Arthritis;Current Pharmaceutical Design;2023-04

3. Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis;Arthritis Research & Therapy;2022-03-21

4. Thérapies ciblant l’inflammation et risque de cancer;Revue du Rhumatisme;2022-01

5. Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches;Biomedicines;2021-10-21